ICON Public Limited Company

NASDAQ:ICLR

Medical - Diagnostics & Research

Healthcare
$195.16 -0.19%

-$0.27 today

Market cap
$14.62B
Beta
1.27
P/E (TTM)
23.0
EPS (TTM)
$6.23
52W Low $66.57High $211.00

Volume 0.55M

Average 1.15M

ICLR Sales of Investments

Cash received from selling or redeeming investments.

ICON Public Limited CompanyNASDAQ: ICLR

Sales of Investments · Q2 FY2026 · quarter ended Jun 2026

Sales of investments grows, but more slowly than its trailing trend

Q2 FY2026 sales of investments of $4.46M rose 830.4% year over year, behind the +19678.1% change in trailing-twelve-month sales of investments. Sequentially, it rose 1596.8% from the prior quarter. Over 3 fiscal years it compounded at +56.2% a year.

Context

  • Sales of investments amounted to 0.1% of revenue in FY2025, unchanged from a year earlier.
  • Sales of investments increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +830.4% toward the trailing-twelve-month pace of +19678.1%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
$4.46M+1596.8% QoQ
Last fiscal yearDec 2025
$9.09M+237.9% YoY
LTMJun 2026
$15.34M+19678.1% YoY
Sales of Investments past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+830.4%——
1 year+237.9%——
3-year CAGR+56.2%——
5-year CAGR——
10-year CAGR——

Sales of Investments history

USD · from the cash flow

Latest · FY2025
9.09M USD
Year-over-year change
+237.9%
4-year CAGR
+106.8%

Sales of Investments vs competitors

How ICLR compares with its peers on the latest reported figures

  • ICLR's LTM Jun 2026 sales of investments of $15.34M is the 2nd largest of the 6 companies compared; the peer median is $0.
  • Its year-over-year change of +19678.1% is the highest of 4, against a peer median of -42.6%.
  • Sales of investments amounts to 0.2% of revenue for ICLR, versus a peer median of 0.0%.
ICLR Competitors Peer median
Sales of Investments for ICLR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CRLCharles River Laboratories International, Inc.LTM Jun 2026$18.06M -42.6%+26.0%0.5%
ICLRICON Public Limited CompanyLTM Jun 2026$15.34M +19678.1%+56.2%0.2%
IQVIQVIA Holdings Inc.LTM Jun 2026$3M +50.0%—0.0%
LHLabcorp Holdings Inc.LTM Jun 2026$0 -100.0%-5.2%0.0%
MEDPMedpace Holdings, Inc.LTM Sep 2026$0 ——0.0%
FTREFortrea Holdings Inc.LTM Jun 2026$0 ——0.0%
Peer median (excluding ICLR) $0-42.6%+10.4%0.0%

Competitors are the stored peer set for ICLR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income153.19M505.3M612.34M791.47M229.34M
Depreciation & Amortization314.99M569.51M585.95M488.5M383M
Deferred Income Tax(60.62M)(124.99M)(85.4M)0(128.92M)
Stock-Based Compensation133.84M70.52M55.67M45.87M102.04M
Change in Working Capital135M(550.22M)(114.82M)(56.51M)(98.1M)
Accounts Receivables95.86M(753.29M)(78.58M)9.39M(169.32M)
Inventory00000
Accounts Payables00000
Other Working Capital39.14M203.07M(36.24M)(65.9M)71.22M
Other Non-Cash Items152.75M93.18M107.3M17.32M548.85M
Operating Cash Flow829.14M563.32M1.16B1.29B1.04B
Capital Expenditures(93.75M)(142.16M)(140.69M)(168.06M)(174.21M)
Acquisitions (Net)(5.92B)(1.91M)(71.77M)(84.16M)(2.54M)
Purchases of Investments(4.06M)(6.09M)(16.81M)(17.26M)(19.87M)
Sales of Investments497K2.39M2.62M2.69M9.09M
Other Investing Activities(10M)1.91M000
Investing Cash Flow(6.02B)(145.87M)(226.65M)(266.79M)(187.53M)
Debt Repayment5.03B(800M)(895M)(360.28M)(29.76M)
Common Stock Issued117.74M35.84M50.97M36.19M9.72M
Common Stock Repurchased0(99.98M)0(500M)(750M)
Dividends Paid00000
Other Financing Activities(30.33M)(34K)(16K)(13.09M)(1.22M)
Financing Cash Flow5.11B(864.17M)(844.04M)(837.18M)(771.26M)
Effect of Forex Changes(7.73M)(16.72M)(997K)(22M)31.1M
Net Change in Cash(88.09M)(463.45M)89.33M160.68M108.51M
Free Cash Flow735.39M421.16M1.02B1.12B861.99M

ICON Public Limited Company

NASDAQ:ICLR

Intrinsic Alpha fair value

Locked

Current Price

$195.16

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.